MLICM
CONE

Metropolitan Life Insurance Company (MetLife)’s CyrusOne Inc Common Stock CONE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CONE Stock Details CONE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-31,076
Closed -$2.79M – 2794
2021
Q4 		$2.79M Buy
31,076
+177
+0.6% +$15K 0.04% 389
2021
Q3 		$2.39M Sell
30,899
-59
-0.2% -$4.44K 0.03% 423
2021
Q2 		$2.21M Sell
30,958
-4,166
-12% -$303K 0.03% 477
2021
Q1 		$2.38M Sell
35,124
-1,138
-3% -$78.9K 0.04% 442
2020
Q4 		$2.65M Buy
36,262
+372
+1% +$27K 0.04% 372
2020
Q3 		$2.51M Sell
35,890
-616
-2% -$48.3K 0.04% 352
2020
Q2 		$2.66M Sell
36,506
-2,964
-8% -$211K 0.05% 322
2020
Q1 		$2.44M Sell
39,470
-1,636
-4% -$99.9K 0.05% 320
2019
Q4 		$2.69M Buy
41,106
+4,126
+11% +$283K 0.04% 386
2019
Q3 		$2.93M Sell
36,980
-1,081
-3% -$72.2K 0.05% 326
2019
Q2 		$2.2M Buy
38,061
+1,507
+4% +$88.3K 0.04% 484
2019
Q1 		$1.92M Buy
36,554
+668
+2% +$35K 0.03% 515
2018
Q4 		$1.9M Buy
35,886
+752
+2% +$43K 0.04% 456
2018
Q3 		$2.23M Buy
35,134
+1,257
+4% +$81.3K 0.04% 455
2018
Q2 		$1.98M Sell
33,877
-2,488
-7% -$135K 0.03% 524
2018
Q1 		$1.86M Buy
36,365
+1,691
+5% +$90.6K 0.03% 575
2017
Q4 		$2.06M Sell
34,674
-153,614
-82% -$9.32M 0.03% 528
2017
Q3 		$11.1M Buy
188,288
+106,975
+132% +$6.38M 0.07% 250
2017
Q2 		$4.53M Buy
81,313
+5,650
+7% +$312K 0.03% 638
2017
Q1 		$3.89M Buy
75,663
+67,080
+782% +$3.3M 0.03% 715
2016
Q4 		$384K Sell
8,583
-40
-0.5% -$1.77K ﹤0.01% 1905
2016
Q3 		$410K Sell
8,623
-2
-0% -$103 ﹤0.01% 1823
2016
Q2 		$480K Sell
8,625
-43,096
-83% -$2.08M ﹤0.01% 1733
2016
Q1 		$2.36M Buy
51,721
+2,849
+6% +$109K 0.02% 845
2015
Q4 		$1.83M Sell
48,872
-1,153
-2% -$40.8K 0.01% 924
2015
Q3 		$1.63M Buy
50,025
+10,009
+25% +$318K 0.01% 991
2015
Q2 		$1.18M Buy
40,016
+9,658
+32% +$302K 0.01% 1186
2015
Q1 		$945K Sell
30,358
-64
-0.2% -$1.89K 0.01% 1220
2014
Q4 		$838K Sell
30,422
-1,409
-4% -$37K 0.01% 1448
2014
Q3 		$765K Buy
31,831
+8,283
+35% +$211K 0.01% 1448
2014
Q2 		$586K Buy
23,548
+2,683
+13% +$58.8K ﹤0.01% 1723
2014
Q1 		$435K Buy
20,865
+32
+0.2% +$696 ﹤0.01% 1911
2013
Q4 		$465K Sell
20,833
-48
-0.2% -$976 ﹤0.01% 1859
2013
Q3 		$396K Buy
20,881
+3,501
+20% +$69.9K ﹤0.01% 1921
2013
Q2 		$360K Buy
+17,380
New +$389K ﹤0.01% 1927

Other funds holding CONE

JCM
Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return
KA
Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CONE Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 31,076 shares — an estimated $2.79M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CONE in Q2 2013 and held it in 35 quarters. The position peaked at $11.1M in Q3 2017. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 31,076 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $2.79M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CyrusOne Inc Common Stock in Q2 2013 and held it in 35 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CyrusOne Inc Common Stock position peaked at $11.1M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.